Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Biodegradable polymeric solid implants developed for long-acting HIV pre-exposure prophylaxis

July 21, 2021

Ionis and Bicycle Therapeutics enter licensing agreement to advance LICA technology

July 14, 2021

Back to the basics for new insights, with new technology

June 25, 2021

Mydecine launches in silico drug discovery program with University of Alberta

June 17, 2021

Tylenol could find role in gene therapy

June 16, 2021

CRISPR and Capsida enter strategic collaboration to develop gene-edited therapies

June 16, 2021

CAMP4 raises funds to expand its platform and advance multiple RNA therapies

June 16, 2021

Shoreline and BeiGene collaborate to develop and commercialize NK-based cell therapies

June 10, 2021

Localized production of protein therapeutics in tumor cells using the SHREAD gene therapy platform

June 7, 2021

Wave Life Sciences presents promising preclinical data for its ADAR editing program

June 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...